BACKGROUND: Our renin IRMA overestimated renin in plasmas with high
prorenin-to-renin ratios. We suspected that the overestimation of renin
was caused less by cross-reactivity of the renin-specific antibody with
prorenin than by a conformational change of prorenin into an enzymatically
active form during the assay. METHODS: Because the inactive form of
prorenin converts slowly into an active form at low temperature, we raised
the assay temperature from 22 degrees C to 37 degrees C, simultaneously
shortening the incubation time from 24 to 6 h. The former IRMA was
performed in <1 working day with these modifications. RESULTS: The
comeasurement of prorenin as renin was eliminated. Reagents were stable at
37 degrees C, and the new and old IRMAs were comparable in terms of
precision and accuracy. The functional lower limit of the assay (4 mU/L)
was below the lower reference limit (9 mU/L). The modified IRMA agreed
closely with the activities measured with an enzyme-kinetic assay. Results
were not influenced by the plasma concentration of angiotensinogen. At
normal angiotensinogen concentrations, the IRMA closely correlated with
the classical enzyme-kinetic assay of plasma renin activity. CONCLUSION:
The modified IRMA, performed at 37 degrees C, avoids interference by
prorenin while retaining the desirable analytical characteristics of the
older IRMA and requiring less time